According to WHO health profile, Iran has better situation in controlling some infection disease like leprosy, dengue fever, tularemia and hepatitis B than United States, even though Iran is in a more dangerous area than the USA. Achieving optimum control for infectious disease in the Middle East requires huge financial costs, equipment and a great time. Some of Iran's actions to control infectious diseases include: special attention of the Iran government to the health issue, training and developing human resources, membership and close cooperation with international organizations like WHO, detecting and monitoring emerging diseases before their arrival and distribution in Iran, expanding and updating national immunization and vaccination program since 1992, national project implementation titled "Health system development plan", supplying and manufacturing most of drugs required in Iran by the Iranian companies as a strategic planning, great coordination between different departments of the MOHME and other relevant institutions to Iran Army and Ministry of Intelligence to prevent the emergence of bioterrorism, and etc. We believe that Iran has obtained an acceptable score in the control of infectious diseases; but it still has very big challenges to reach the ideal level.
© Indian Virological Society 2020.
Conflict of interest statement
Conflict of interestAll authors report no conflicts of interest relevant to this article.
Surprising decline in Iran's growth rates.Popul Today. 1997 Nov;25(11):4. Popul Today. 1997. PMID: 12321257
2012-2025 Roadmap of I.R.Iran's Disaster Health Management.PLoS Curr. 2012 Jul 16;4:e4f93005fbcb34. doi: 10.1371/4f93005fbcb34. PLoS Curr. 2012. PMID: 22953239 Free PMC article.
Assessment of the Effects of Economic Sanctions on Iranians' Right to Health by Using Human Rights Impact Assessment Tool: A Systematic Review.Int J Health Policy Manag. 2018 May 1;7(5):374-393. doi: 10.15171/ijhpm.2017.147. Int J Health Policy Manag. 2018. PMID: 29764102 Free PMC article. Review.
Challenges to the future development of Iran's protected areas system.Environ Manage. 2012 Oct;50(4):750-65. doi: 10.1007/s00267-012-9895-5. Epub 2012 Jul 14. Environ Manage. 2012. PMID: 22797765 Review.
Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy.Global Health. 2016 Jun 8;12(1):31. doi: 10.1186/s12992-016-0168-6. Global Health. 2016. PMID: 27267898 Free PMC article.
Cited by 1 article
A glance at the prevalence of coronavirus disease 19 (COVID-19) in Iran: Strengths and weaknesses.Infect Control Hosp Epidemiol. 2020 May 4:1-3. doi: 10.1017/ice.2020.193. Online ahead of print. Infect Control Hosp Epidemiol. 2020. PMID: 32362292 Free PMC article. No abstract available.